Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramila Rijal

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Current Opinion in Virology|July 1, 2023
A review of broadly protective monoclonal antibodies to treat Ebola virus diseasePramila Rijal, Francesca R Donnellan
Journal of Virology|January 27, 2025
A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunityHolly L Sadler, Pramila Rijal, Tiong Kit Tan, et al.
Journal of Virology|December 8, 2017
Characterization of Influenza Virus Pseudotyped with Ebolavirus GlycoproteinJulie Huiyuan Xiao, Pramila Rijal, Lisa Schimanski, et al.
Frontiers in Immunology|July 25, 2025
Single-cycle, pseudotyped reporter influenza virus to facilitate evaluation of treatment strategies for avian influenza, Ebola and other highly infectious diseases <i>in vivo</i>Tiong Kit Tan, Pramila Rijal, Kuan-Ying A Huang, et al.
Thorax|September 5, 2020
Lung-targeting lentiviral vector for passive immunisation against influenzaTiong Kit Tan, Toby P E Gamlen, Pramila Rijal, et al.
Tropical Medicine and Infectious Disease|August 27, 2021
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation AssayEmma M Bentley, Samuel Richardson, Mariliza Derveni, et al.
Ebiomedicine|May 7, 2023
Post COVID-19 condition after delta infection and omicron reinfection in children and adolescentsNina Urke Ertesvåg, Arild Iversen, Bjørn Blomberg, et al.
Elife|January 10, 2023
Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitorsMatheswaran Kandasamy, Uzi Gileadi, Pramila Rijal, et al.
The Journal of General Virology|June 27, 2018
Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) virusesKerstin Beer, Mian Dai, Steven Howell, et al.
The Journal of Clinical Investigation|May 27, 2015
Focused antibody response to influenza linked to antigenic driftKuan-Ying A Huang, Pramila Rijal, Lisa Schimanski, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Current Opinion in Virology|July 1, 2023
A review of broadly protective monoclonal antibodies to treat Ebola virus diseasePramila Rijal, Francesca R Donnellan
Journal of Virology|January 27, 2025
A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunityHolly L Sadler, Pramila Rijal, Tiong Kit Tan, et al.
Journal of Virology|December 8, 2017
Characterization of Influenza Virus Pseudotyped with Ebolavirus GlycoproteinJulie Huiyuan Xiao, Pramila Rijal, Lisa Schimanski, et al.
Frontiers in Immunology|July 25, 2025
Single-cycle, pseudotyped reporter influenza virus to facilitate evaluation of treatment strategies for avian influenza, Ebola and other highly infectious diseases <i>in vivo</i>Tiong Kit Tan, Pramila Rijal, Kuan-Ying A Huang, et al.
Thorax|September 5, 2020
Lung-targeting lentiviral vector for passive immunisation against influenzaTiong Kit Tan, Toby P E Gamlen, Pramila Rijal, et al.
Tropical Medicine and Infectious Disease|August 27, 2021
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation AssayEmma M Bentley, Samuel Richardson, Mariliza Derveni, et al.
Ebiomedicine|May 7, 2023
Post COVID-19 condition after delta infection and omicron reinfection in children and adolescentsNina Urke Ertesvåg, Arild Iversen, Bjørn Blomberg, et al.
Elife|January 10, 2023
Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitorsMatheswaran Kandasamy, Uzi Gileadi, Pramila Rijal, et al.
The Journal of General Virology|June 27, 2018
Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) virusesKerstin Beer, Mian Dai, Steven Howell, et al.
The Journal of Clinical Investigation|May 27, 2015
Focused antibody response to influenza linked to antigenic driftKuan-Ying A Huang, Pramila Rijal, Lisa Schimanski, et al.
Pageof 7